期刊文献+

IgA肾病患者CpG岛组蛋白H3赖氨酸4三甲基化水平的研究 被引量:2

CpG array analysis of histone H3 lysine 4 trimethylation in patients with IgA nephropathy
下载PDF
导出
摘要 目的研究IgA肾病患者CpG岛组蛋白H3赖氨酸4三甲基化(H3K4me3)水平。方法采用染色质免疫共沉淀联合芯片技术(ChIP-chip)对15例IgA肾病患者和15例健康者的外周血单个核细胞(PBMCs)H3K4me3进行高通量的筛选,染色质免疫共沉淀-实时定量聚合酶链反应(ChIP-qPCR)验证芯片结果。定量反转录聚合酶链反应(qRT-PCR)检测H3K4me3显著差异基因的mRNA表达水平。结果与健康对照组相比,IgA肾病患者的83个基因存在H3K4me3显著差异,其中有39个基因显示H3K4me3水平增高,44个基因H3K4me3水平降低;ChIP-qPCR验证结果与CpG岛芯片结果相符,基因H3K4me3异常变化影响mRNA的表达。结论 IgA肾病患者PBMCs基因组H3K4me3存在显著改变,异常基因有助于研究IgA肾病的发病机制。 Objective To investigate the aberrance of histone H3 lysine 4 trimethylation(H3K4me3) in patients with IgA nephropathy(IgAN).Methods In 15 patients with IgAN and 15 healthy volunteers,H3K4me3 variations in peripheral blood mononuclear cells(PBMCs) were analyzed using chromatin immunoprecipitation and microarray analysis(ChIP-chip).ChIP real-time PCR was used to validate the microarray results.Quantitative real-time PCR(qRT-PCR) was carried out to examine the correlations between the mRNA expression profiles and H3K4me3 levels.Results We identified 83 genes that displayed significant H3K4me3 differences in IgAN patients compared with healthy subjects.Among them,39 genes showed increased H3K4me3 and 44 genes had decreased H3K4me3 levels.The results of ChIP real-time PCR were well consistent with the microarray data.Quantitative RT-PCR revealed the correlations between the mRNA expressions and the methylation levels of H3K4me3.Conclusion IgAN patients have significant alterations in H3K4me3,and the genes with aberrant H3K4me3 may provide insights into the pathogenesis of IgAN.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2011年第9期1575-1578,共4页 Journal of Southern Medical University
基金 广西壮族自治区自然科学基金(2010GXNSFA013273)
关键词 IGA肾病 组蛋白H3赖氨酸4 三甲基化 染色质免疫共沉淀 IgA nephropathy histone H3 lysine 4 trimethylation chromatin immunoprecipitation
  • 相关文献

参考文献21

  • 1Eijgenraam JW, van Kooten C. IgA1 glycosylation in IgA nephropathy: as sweet as it can be[J]. Kidney Int, 2008, 73 (10): 1106-8.
  • 2Novak J, Julian BA, Tomana M, et al. IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy [J]. Semin Nephrol, 2008, 28 (1): 78-87.
  • 3Zhu L, Tang W, Li G, et al. Interaction between variants of two glycosyltransferase genes in IgA nephropathy[J]. Kidney Int, 2009, 76(2): 190-8.
  • 4Haas M. Histology and immtmohistology of IgA nephropathy[J]. J Nephrol, 2005, 18(6): 676-80.
  • 5张丽,戴勇,胡成效,张艳亮.类风湿关节炎患者外周血单个核细胞组蛋白H3赖氨酸4三甲基化水平检测及意义[J].广东医学,2009,30(8):1084-1087. 被引量:2
  • 6Wu H, Ji H. JAMIE: joint analysis of multiple ChiP-chip experiments[J]. Bioinformatics, 2010, 26(15): 1864-70.
  • 7Livak K J, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method[J]. Methods, 2001, 25(4): 402-8.
  • 8Anastasiadou C, Malousi A, Maglaveras N, et al. Human epigenome data reveal increased CpG methylation in alternatively spliced sites and putative exonic splicing enhancers[J]. DNA Cell Biol, 2011, 30(5): 267-75.
  • 9Arai E, Kanai Y. Genetic and epigenetic alterations during renal carcinogenesis[J]. Int J Clin Exp Pathol, 2010, 4(1): 58-73.
  • 10Hashimoto H, Vertino PM, Cheng X. Molecular coupling of DNA methylation and histone methylation[J]. Epigenomics, 2010, 2(5): 657-69.

二级参考文献18

  • 1Li YJ, Du Y, Li CX, et al. Family-based association study showing that immunoglobulin A nephropathy is associated with the polymorphisms 2093C and 2180T in the 3'untranslated region of the megsin gene. J Am Soc Nephrol, 2004,15:1739-1743.
  • 2Inagi R, Miyata T, Nangaku M, et al. Transcriptional regulation of a mesangium-predominant gene, megsin. J Am Soc Nephrol, 2002,13:2715-2722.
  • 3Suzuki D, Miyata T, Nangaku M, et al. Expression of megsin mRNA, a novel mesangium-predominant gene, in the renal tissues of various glomerular diseases. J Am Soc Nephrol, 1999,10:2606-2613.
  • 4Guo B, Koya D, Isono M, et al. Peroxisome proliferator-activated receptor-gamma ligands inhibit TGF-beta 1- induced fibronectin expression in glomerular mesangial cells. Diabetes, 2004,53:200-208.
  • 5ARNETY F C, EDWORTHY S M, BLOCH D A, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis[ J]. Arthritis Rheum, 1988, 31 (3) : 315 -324.
  • 6HUEBERT D J, KAMAL M, O' DONOVAN A, et al. Genome - wide analysis of histone modifications by ChIP - on - chip [ J ]. Methods, 2006, 40(4): 365-369.
  • 7LIVAK K J, SCHMITYGEN T D. Analysis of relative gene expression data using real - time quantitative PCR and the 2 ( - Delta Delta C(T) ) Method[J]. Methods, 2001, 25(4) : 402 -408.
  • 8LIANG G, LIN J C, WEI C, et al. Distinct localization of histone H3 acetylation and H3 - K4 methylation to the transcription start sites in the human genome [J]. Proc Natl Acad Sci, 2004, 101 (19) : 7 357 -7 362.
  • 9LI H G, WANG Q, LI H M, et al. PAX3 and PAX3 - FKHR promote rhabdomyosarcoma cell survival through downregulation of PTEN[J]. Cancer Lett, 2007, 253(2) : 215 -223.
  • 10MARGUE C M, BERNASCONI M, BARR F G, et al. Transcriptional modulation of the anti - apoptotic protein BCL - XL by the paired box transcription factors PAX3 and PAX3/FKHR [ J]. Oncogene, 2000, 19(25) : 2 921 -2 929.

共引文献4

同被引文献22

  • 1王国兵,李成荣,祖莹,杨军,付劲蓉.儿童微小病变型肾病综合征致病相关基因筛查[J].实用儿科临床杂志,2006,21(19):1317-1319. 被引量:3
  • 2Gipson DS, Massengill SF, Yao L,et al. Management ofchildhood onset nephrotic syndrome[J].Pediatrics, 2009, 124(2): 747-757. DOI: 10.1542/peds.2008-1559.
  • 3Yang X,Lay F,Han H,et al. Targeting DNA methylation forepigenetic therapy[J].Trends Pharmacol Sci. 2010,31(11): 536-546. DOI: 10.1016/j.tips.2010.08.001.
  • 4Bergman Y, Cedar H. DNA methylation dynamics in healthand disease[J].Nat Struct Mol Biol, 2013, 20(3): 274 - 281.DOI: 10.1038/nsmb.2518.
  • 5Zhang L,Dai Y,Peng W, et al. Genome - wide analysis ofhistone H3 lysine 4 trimethylation in peripheral bloodmononuclear cells of minimal change nephrotic syndromepatientsfj].Am J Nephrol, 2009, 30(6): 505 - 513. DOI:10.1159/000243811.
  • 6Wei CC, Yu IW, Lin HW, et al. Occurrence of infectionamong children with nephrotic syndrome duringhospitalizations[J].Nephrology(Carlton), 2012,17(8): 681-688.DOI: 10.1111/j.l440-1797.2012.01650.x.
  • 7Teodoridis JM, Hall J, Marsh S, et al. CpG island methylationof DNA damage response genes in advanced ovarian cancer[J].Cancer Res, 2005, 65(19): 8961 -8967. DOI: 10.1158/0008-5472.CAN-05-1187.
  • 8Reddy MA, Natarajan R. Epigenetics in diabetic kidney disease[J].J Am Soc Nephrol, 2011,22(12): 2182-2185. DOI: 10.1681/ASN.2011060629.
  • 9Moon S, Um SJ, Kim EJ. Role of Asxll in kidney podocytedevelopment via its interaction with Wtip[J], Biochem BiophysRes Commun, 2015, 466(3): 560 - 566. DOI: 10.1016/j.bbrc.2015.09.077.
  • 10Tharaux PL, Huber TB. How many ways can a podocyte die?[J].Semin Nephrol, 2012, 32(4): 394 - 404. DOI: 10.1016/j.semnephrol.2012.06.011.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部